Cyclopharm (CYC) Short Interest
Cyclopharm (ASX:CYC) had 0.00% of shares reported as short positions as of 10 Aug 2026, representing 330 shares. Cyclopharm operates in the Health Care Equipment & Services industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Cyclopharm
Cyclopharm is a global radiopharmaceutical company focused on lung imaging solutions. Their flagship product, Technegas, is used for pulmonary embolism diagnosis and other lung conditions. The company aims to advance nuclear pulmonology imaging through innovation and a commitment to superior patient care.
Short position
Cyclopharm (ASX:CYC) has 0.00% of its shares on issue reported as short positions as of 10 Aug 2026, or about 330 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.21% in September 2025. CYC is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Weekly context: The 10 most shorted ASX stocks — Week 35, 2026.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4CYC intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
Company
AI-generated research profile of Cyclopharm
About
website
address
More Health Care Equipment & Services Stocks
Other shorted stocks in this sector
Be the first to discuss CYC
Start a research thread or post the first pulse update